Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 12
Submit an article Journal homepage
1,380
Views
7
CrossRef citations to date
0
Altmetric
Short Report

Measles in pregnancy: a threat for Italian women?

Serena Marchia Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-6817-2461View further author information
ORCID Icon,
Martina Montia Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-2173-7269View further author information
ORCID Icon,
Simonetta Viviania Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyORCID Iconhttps://orcid.org/0000-0002-3652-5082View further author information
ORCID Icon,
Emanuele Montomolia Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy;b VisMederi srl, Siena, ItalyORCID Iconhttps://orcid.org/0000-0001-7595-4974View further author information
ORCID Icon &
Claudia Maria Trombettaa Department of Molecular and Developmental Medicine, University of Siena, Siena, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7229-9919View further author information
ORCID Icon
Pages 2851-2853 | Received 25 Jan 2019, Accepted 11 May 2019, Published online: 20 Jun 2019

References

  • Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016;2:16049. doi:10.1038/nrdp.2016.49.
  • Filia A, Bella A, Rota M, Tavilla A, Magurano F, Baggieri M, Nicoletti L, Iannazzo S, Pompa M, Declich S. Analysis of national measles surveillance data in Italy from October 2010 to December 2011 and priorities for reaching the 2015 measles elimination goal. Euro Surveill. 2013;18(20): 1–7.
  • Istituto Superiore di Sanità. Morbillo Aspetti Epidemiologici; 2017 [ accessed 11 January 2019]. http://www.epicentro.iss.it/morbillo/epidemiologia-italia.
  • Istituto Superiore di Sanità. Measles in Italy: weekly bullettin; 2017.
  • Signorelli C, Odone A, Cella P, Iannazzo S, D’Ancona F, Guerra R. Infant immunization coverage in Italy (2000–2016). Ann Ist Super Sanita. 2017;53(3):231–37. doi:10.4415/ANN_17_03_09.
  • O’Connor P, Jankovic D, Muscat M, Ben-Mamou M, Reef S, Papania M, Singh S, Kaloumenos T, Butler R, Datta S. Measles and rubella elimination in the WHO Region for Europe: progress and challenges. Clin Microbiol Infect. 2017;23(8):504–10. doi:10.1016/j.cmi.2017.01.003.
  • Adamo G, Sturabotti G, D’Andrea E, Baccolini V, Romano F, Iannazzo S, Marzuillo C, Villari P. The end of measles and congenital rubella: an achievable dream? Ann Ig. 2017;29(1):1–26. doi:10.7416/ai.2017.2128.
  • Manikkavasagan G, Ramsay M. The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review. J Obstet Gynaecol. 2009;29(7):572–75. doi:10.1080/01443610903104478.
  • Kobayashi K, Tajima M, Toishi S, Fujimori K, Suzuki Y, Udagawa H. Fetal growth restriction associated with measles virus infection during pregnancy. J Perinat Med. 2005;33(1):67–68. doi:10.1515/JPM.2005.011.
  • Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign. PLoS One. 2013;8(1):e55043. doi:10.1371/journal.pone.0055043.
  • ISTAT. Database ISTAT Popolazione e famiglie. 2016; [ accessed 13 April 2018]. http://dati.istat.it/.
  • Salmaso S,MC, Rota ML, Atti CD, Tozzi AE, Kreidl P. Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions. ICONA Study Group. Bull World Health Organ. 1999;77:843–51.
  • WHO. Childhood vaccination coverage in Italy: results of a seven-region survey. The Italian vaccine coverage survey working group. Bull World Health Organ. 1994;72(6):885–95.
  • Bechini A, Levi M, Boccalini S, Tiscione E, Panatto D, Amicizia D, Bonanni P. Progress in the elimination of measles and congenital rubella in Central Italy. Hum Vaccin Immunother. 2013;9(3):649–56. doi:10.4161/hv.23261.
  • Plans P, de Ory F, Campins M, Alvarez E, Paya T, Guisasola E, Compte C, Vellbe K, Sanchez C, Lozano MJ, et al. Prevalence of anti-rubella, anti-measles and anti-mumps IgG antibodies in neonates and pregnant women in Catalonia (Spain) in 2013: susceptibility to measles increased from 2003 to 2013. Eur J Clin Microbiol Infect Dis. 2015;34(6):1161–71. doi:10.1007/s10096-015-2339-4.
  • Bodilis H, Goffinet F, Krivine A, Andrieu T, Anselem O, Tsatsaris V, Rozenberg F, Launay O. Determinants of measles seroprevalence among pregnant women in Paris, France. Clin Microbiol Infect. 2014;20(8):O501–4. doi:10.1111/1469-0691.12469.
  • Ministero della Salute. Piano nazionale per l’eliminazione del morbillo e della rosolia congenita 2010–2015. 2011. p. 1–36. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1519_allegato.pdf

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.